newsfilter
← Latest News
PR Newswire·

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that ...